XRP
All compounds
GutSkinHealingAnti-inflammatory

KPV

α-MSH Tripeptide | Anti-inflammatory

Typical Dose
200–500 mcg daily
Route
Injectable
Price (AUD)
$120
Vial size

Bundle & Supplies

XRP50
Add-on · Recommended

Pre-filled Disposable Pen

Your compound pre-loaded into a sterile, single-patient disposable injection pen. Eliminates vial reconstitution and syringe drawing. Twist the dose dial, press, done.

Disposable penDial-a-doseSealed sterile
Upgrade Price
+$50

Overview

What is KPV?

KPV is the C-terminal tripeptide (Lys-Pro-Val) of α-MSH, studied for its potent anti-inflammatory action in the gut, skin and connective tissue — without the pigmentation effects of full α-MSH.

Mechanism of Action

Inhibits NF-κB signaling and pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6), reduces mast cell degranulation, and supports mucosal barrier integrity.

Key Benefits

  • Down-regulates systemic and gut inflammation
  • Supports gut-lining repair (IBD/colitis research)
  • Calms inflammatory skin conditions
  • Synergistic with BPC-157 and TB-500 for healing

Research Indications

Inflammatory bowel researchMost Effective
Eczema, psoriasis, dermatitisEffective
Mast cell / allergic inflammationEffective
Wound healingModerate

Research Protocols

Disclaimer

These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Conservative200 mcg1x dailySubcutaneous or oral capsule
Standard starting dose300 mcg1x dailySubcutaneous
Typical maintenance500 mcg1x dailySubcutaneous
Maximum500 mcg2x dailySubcutaneous

Peptide Interactions

BPC-157
Gut + soft-tissue healing stack
Synergistic
TB-500
Synergistic
KLOW
KPV is already a component
Compatible
Immunosuppressants
Monitor

Side Effects & Safety

Common Side Effects

  • Generally very well tolerated
  • Mild injection-site reaction
  • Rare transient headache

Safety Guidelines

  • For laboratory research use only — not for human consumption
  • Store reconstituted vials at 2–8°C, use within 30 days
  • Rotate injection sites to avoid local irritation
  • Discontinue and consult a clinician if adverse reactions occur

Quality Indicators

  • ≥99% purity verified by HPLC
  • Third-party tested for sterility
  • Lyophilized in sealed multi-dose vial
  • Bacteriostatic water reconstitution
  • Refrigerated cold-chain shipping

What to Expect

  1. 1
    Week 1
    Reduced inflammatory symptoms
  2. 2
    Week 2–4
    Gut and skin improvements
  3. 3
    Week 5–8
    Sustained mucosal and barrier repair

Need a different compound?

Browse all peptides